FedEx (FDX.US) released an earnings report for the fourth quarter of fiscal-2022 as well as for the full fiscal year yesterday after the close of the Wall Street session. While results for fiscal-Q4 2022 missed market expectations, the company released a set of upbeat forecasts for the fiscal year 2023 (June 2022 - May 2023), resulting in a strong upward move in the company's shares today.
FedEx reported fiscal-Q4 revenue at $24.4 billion, slightly below $24.57 billion expected by the analysts. Operating profit reached $2.23 billion (exp. $2.28 billion), translating into operating margin of 9.2% (exp. 9.4%). Adjusted EPS for the final quarter of fiscal-2022 was reported at $6.87 and was in-line with market expectations.
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appSales and operating income was slightly lower than expected but an optimistic forecast for fiscal-2023 allowed investors to look past these small disappointments with ease. FedEx said that it expects adjusted EPS for full fiscal-2023 to reach $22.50-24.50. This is an upbeat forecast as the market expected the company to report adjusted EPS of $22.36 for the fiscal-year that has begun this month. Package price increases coupled with lower costs, resulting from labor shortage easing, have put the company on a good track to outperform in fiscal-2023.
Shares of FedEx (FDX.US) trade 8% higher today following release of fiscal-Q4 earnings report and upbeat forecasts for fiscal-2023. Stock jumped above the 38.2% retracement as well as the upper limit of the Overbalance structure. Note that the stock also moved above previous local high, boosting chances for the downtrend to end. A near-term resistance zone can be found at $255.50. Source: xStation5
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.